EN
HI
Summary
As of 16 Sep, 2026, Gufic Biosciences stock price is ₹425.1. During the trading session, the stock has moved between an intraday low of ₹418.00 and an intraday high of ₹431.90. Over the last 52 weeks, Gufic Biosciences has traded between ₹268.00 and ₹467.80.
The stock has recorded a trading volume of 60,589 shares,. Its Average Traded Price (ATP) is ₹425.63, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 19 @ ₹425.10.
Gufic Biosciences has an upper circuit limit of ₹510.10 and a lower circuit limit of ₹340.10. The total value traded stands at ₹2.58 CR, and the delivery percentage for the day is 53.01%.
The stock is currently traded with a market lot size of 1. Gufic Biosciences also offers a dividend yield of 0.02%.
Gufic Biosciences Share Price Chart
Gufic Biosciences Share Key Metrics
Volume
60589.00
Market Cap
4263.01 CR
LTQ@LTP
19@425.10
ATP
425.63
Var Margin
18.44 %
Circuit Range
340.1-510.1
Delivery %
53.01 %
Value
2.58 CR
ASM/GSM
No
Market Lot
1
Gufic Biosciences Fundamentals
P/E Ratio
57.92
P/B Ratio
6.19
Div. Yield
0.02
Sector P/E
41.67
Sector P/B
3.6
Sec. Div. Yield
0.51
Gufic Biosciences Resistance and Support
Pivot 425.05
Resistance
First Resistance
432
Second Resistance
438.9
Third Resistance
445.85
Support
First Support
418.15
Second Support
411.2
Third Support
404.3
Gufic Biosciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Sep 15 2026 | 425 | 425.1 | 0.00% | 431.9 | 418 |
| Fri Sep 11 2026 | 423.25 | 425.1 | 0.58% | 431.95 | 418.1 |
| Thu Sep 10 2026 | 429.89 | 422.64 | -1.45% | 432.2 | 419.1 |
Gufic Biosciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-05-29 | Audited Results & Final Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-30 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results & Others |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Gufic Biosciences News
Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Credit Rating
Gufic BioSciences' credit ratings for its bank facilities have been reaffirmed by CRISIL Ratings. The long-term rating is CRISIL A-/Stable and the short-term rating is CRISIL A2+. Total rated bank facilities have increased to Rs. 516 crore from Rs. 425 crore.
Sep 08 2026 18:51:24
Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Gufic BioSciences uploaded the audio recording of its earnings conference call held on August 17, 2026. Investors can access the recording via the company's website. A written transcript will be submitted shortly.
Aug 17 2026 18:31:13
Gufic Biosciences Management
| Name | Position |
|---|---|
| Ami Shah | Company Secretary & Compliance Officer |
| Jayesh P Choksi | Chairman & Managing Director |
Gufic Biosciences Similar Stocks
Gujarat Themis Biosyn Ltd.
430.45
7.80 (1.85%)
Artemis Medicare Services Ltd.
330.55
-14.35 (4.16%)
Supriya Lifescience Ltd.
874.95
-26.80 (2.97%)
RPG Life Sciences Ltd.
2718.80
20.20 (0.75%)
SMS Pharmaceuticals Ltd.
410.15
-53.30 (11.50%)
Aarti Drugs Ltd.
426.35
-2.15 (0.50%)
Unichem Laboratories Ltd.
519.05
-20.65 (3.83%)
Kwality Pharmaceuticals Ltd.
3430.60
-212.70 (5.84%)
Indraprastha Medical Corporation Ltd.
354.55
-0.45 (0.13%)
Solara Active Pharma Sciences Ltd.
715.80
-33.35 (4.45%)
Gufic Biosciences FAQs
The Buying Price of Gufic Biosciences share is 425.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Gufic Biosciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Gufic Biosciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Gufic Biosciences shares is 57.92. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Gufic Biosciences shares is 6.19. Useful to assess the stock's value relative to its book value.
To assess Gufic Biosciences’s valuation compare Sector P/E, P/B which are 41.67 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Gufic Biosciences is 4263.01 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Gufic Biosciences share price is 467.80 & 268.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Gufic Biosciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in GUFICBIO
